A detailed history of Plancorp, LLC transactions in Novartis Ag stock. As of the latest transaction made, Plancorp, LLC holds 4,796 shares of NVS stock, worth $530,245. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,796
Previous 4,793 0.06%
Holding current value
$530,245
Previous $463,000 10.15%
% of portfolio
0.02%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$92.57 - $107.37 $277 - $322
3 Added 0.06%
4,796 $510,000
Q1 2024

May 14, 2024

BUY
$95.27 - $108.47 $1,524 - $1,735
16 Added 0.33%
4,793 $463,000
Q3 2023

Nov 08, 2023

BUY
$94.73 - $105.13 $1,420 - $1,576
15 Added 0.31%
4,777 $486,000
Q1 2023

May 11, 2023

BUY
$80.03 - $92.81 $320 - $371
4 Added 0.08%
4,762 $438,000
Q4 2022

Feb 14, 2023

SELL
$75.55 - $92.52 $5,439 - $6,661
-72 Reduced 1.49%
4,758 $431,000
Q3 2022

Nov 10, 2022

SELL
$74.61 - $87.26 $5,819 - $6,806
-78 Reduced 1.59%
4,830 $367,000
Q2 2022

Aug 04, 2022

SELL
$80.52 - $93.75 $75,125 - $87,468
-933 Reduced 15.97%
4,908 $415,000
Q1 2022

May 13, 2022

BUY
$80.11 - $90.62 $881 - $996
11 Added 0.19%
5,841 $513,000
Q1 2021

May 14, 2021

SELL
$83.5 - $98.47 $39,996 - $47,167
-479 Reduced 7.59%
5,830 $498,000
Q3 2020

Nov 16, 2020

SELL
$82.14 - $91.0 $19,960 - $22,113
-243 Reduced 3.71%
6,309 $549,000
Q2 2020

Aug 11, 2020

SELL
$80.93 - $91.1 $566 - $637
-7 Reduced 0.11%
6,552 $572,000
Q1 2020

May 14, 2020

SELL
$70.67 - $99.01 $13,921 - $19,504
-197 Reduced 2.92%
6,559 $541,000
Q4 2019

Feb 03, 2020

SELL
$84.35 - $95.37 $5,061 - $5,722
-60 Reduced 0.88%
6,756 $640,000
Q3 2019

Nov 12, 2019

SELL
$85.54 - $94.26 $29,596 - $32,613
-346 Reduced 4.83%
6,816 $592,000
Q2 2019

Aug 13, 2019

SELL
$75.4 - $92.8 $25,862 - $31,830
-343 Reduced 4.57%
7,162 $654,000
Q1 2019

May 14, 2019

BUY
$75.32 - $86.15 $25,533 - $29,204
339 Added 4.73%
7,505 $722,000
Q4 2018

Feb 14, 2019

SELL
$73.66 - $82.02 $29,095 - $32,397
-395 Reduced 5.22%
7,166 $615,000
Q3 2018

Nov 13, 2018

SELL
$66.94 - $77.43 $6,359 - $7,355
-95 Reduced 1.24%
7,561 $651,000
Q2 2018

Aug 14, 2018

BUY
$64.91 - $73.36 $496,950 - $561,644
7,656 New
7,656 $578,000
Q4 2017

Jan 19, 2018

SELL
$72.33 - $77.64 $271,237 - $291,150
-3,750 Closed
0 $0
Q3 2017

Oct 11, 2017

BUY
$74.14 - $77.27 $278,025 - $289,762
3,750
3,750 $322,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Plancorp, LLC Portfolio

Follow Plancorp, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plancorp, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plancorp, LLC with notifications on news.